Pharmaceutical Approval Update.

Pharmaceutical Approval Update. P T. 2018 Jul;43(7):394-395 Authors: Choy M Abstract Fostamatinib (Tavalisse) for thrombocytopenia in adults with chronic immune thrombocytopenia; coagulation factor Xa (recombinant), inactivated-zhzo (Andexxa) for the reversal of anticoagulation; epoetin alfa-epbx (Retacrit), a biosimilar for the treatment of anemia. PMID: 30013295 [PubMed]
Source: P and T - Category: Drugs & Pharmacology Tags: P T Source Type: research